文献速递皮肤肿瘤

全基因组微小RNA筛选揭示miR-203在黑色素瘤转移中的作用

Genome-Wide Screen for MicroRNAs Reveals a Role for miR-203 in Melanoma Metastasis.
PubMed 文献 · J Invest Dermatol · 2018-02-13

研究比较了癌症基因组图谱中 primary 与转移性黑色素瘤的 miRNome,发现转移性黑色素瘤中 miR-203 丰度较低,且低 miR-203 与转移性疾病较差的总生存相关。MIR203 启动子 CpG 甲基化与 miR-203 表达负相关,去甲基化剂 5-aza-2-deoxycytidine 可诱导 miR-203 表达。体外过表达 miR-203 抑制黑色素瘤细胞运动、集落形成、球体形成及血管生成诱导能力;体内抑制异种移植瘤生长并减少淋巴结和肺转移。SLUG 被证明是 miR-203 的靶点。

要点

  • 转移性黑色素瘤中miR-203表达降低,与较差总生存相关。
  • MIR203启动子CpG甲基化负调控miR-203表达。
  • miR-203通过靶向SLUG抑制黑色素瘤转移,具有治疗潜力。

核心结论

  • miR-203在黑色素瘤中作为抑癌因子,抑制转移的早期和晚期步骤,恢复miR-203具有治疗潜力。

研究设计与样本

  • 基于癌症基因组图谱数据集的miRNome比较分析,结合黑色素瘤细胞系体外实验和体内异种移植模型。

主要发现

  • 转移性黑色素瘤中miR-203丰度低于原发性黑色素瘤,低miR-203与转移性疾病较差的总生存相关。
  • MIR203启动子多个CpG甲基化水平与miR-203表达负相关,5-aza-2-deoxycytidine处理诱导miR-203表达并伴随启动子CpG去甲基化。
  • 黑色素瘤细胞系中miR-203表达低于原代黑素细胞。
  • 过表达miR-203抑制黑色素瘤细胞运动、集落形成、球体形成及血管生成诱导能力。
  • 体内miR-203抑制异种移植瘤生长并减少淋巴结和肺转移;SLUG为miR-203靶点,敲低SLUG重现miR-203效应,恢复SLUG逆转miR-203介导的运动抑制。

临床怎么用

  • miR-203表达水平可能作为转移性黑色素瘤预后参考指标。
  • 去甲基化剂可能通过恢复miR-203表达发挥治疗作用,但需进一步临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Melanoma is one of the deadliest human cancers with limited therapeutic options. MicroRNAs are a class of short noncoding RNAs regulating gene expression at the post-transcriptional level. To identify important miRNAs in melanoma, we compared the miRNome of primary and metastatic melanomas in The Cancer Genome Atlas dataset and found lower miR-203 abundance in metastatic melanoma. Lower level of miR-203 was associated with poor overall survival in metastatic disease. We found that the methylation levels of several CpGs in the MIR203 promoter negatively correlated with miR-203 expression and that treatment with the demethylating agent 5-aza-2-deoxycytidine induced miR-203 expression, which was associated with demethylation of the promoter CpGs, in melanoma cell lines. In vitro, there was a decreased expression of miR-203 in melanoma cell lines in comparison with primary melanocytes. Ectopic overexpression of miR-203 suppressed cell motility, colony formation, and sphere formation as well as the angiogenesis-inducing capacity of melanoma cells. In vivo, miR-203 inhibited xenograft tumor growth and reduced lymph node and lung metastasis. SLUG was shown as a target of miR-203, and knockdown of SLUG recapitulated the effects of miR-203, whereas its restoration was able to reverse the miR-203-mediated suppression of cell motility. These results establish a role for miR-203 as a tumor suppressor in melanoma which suppresses both early and late steps of metastasis. Hence, restoration of miR-203 has therapeutic potential in melanoma.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Lohcharoenkal W, Das Mahapatra K, Pasquali L, et al. Genome-Wide Screen for MicroRNAs Reveals a Role for miR-203 in Melanoma Metastasis. J Invest Dermatol. 2018. PMID: 29104160. doi:10.1016/j.jid.2017.09.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。